|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:C1orf174-CLCN7 (FusionGDB2 ID:11321) |
Fusion Gene Summary for C1orf174-CLCN7 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: C1orf174-CLCN7 | Fusion gene ID: 11321 | Hgene | Tgene | Gene symbol | C1orf174 | CLCN7 | Gene ID | 339448 | 1186 |
| Gene name | chromosome 1 open reading frame 174 | chloride voltage-gated channel 7 | |
| Synonyms | - | CLC-7|CLC7|HOD|OPTA2|OPTB4|PPP1R63 | |
| Cytomap | 1p36.32 | 16p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | UPF0688 protein C1orf174RP13-531C17.2 | H(+)/Cl(-) exchange transporter 7chloride channel 7 alpha subunitchloride channel protein 7chloride channel, voltage-sensitive 7protein phosphatase 1, regulatory subunit 63 | |
| Modification date | 20200313 | 20200315 | |
| UniProtAcc | . | P51798 | |
| Ensembl transtripts involved in fusion gene | ENST00000361605, ENST00000486765, | ENST00000566812, ENST00000262318, ENST00000382745, ENST00000448525, | |
| Fusion gene scores | * DoF score | 6 X 6 X 4=144 | 8 X 5 X 6=240 |
| # samples | 7 | 8 | |
| ** MAII score | log2(7/144*10)=-1.04064198449735 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/240*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: C1orf174 [Title/Abstract] AND CLCN7 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | C1orf174(3809447)-CLCN7(1509188), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across C1orf174 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CLCN7 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | KIRC | TCGA-AS-3777-01A | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| ChimerDB4 | LIHC | TCGA-DD-A115-01A | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
Top |
Fusion Gene ORF analysis for C1orf174-CLCN7 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000361605 | ENST00000566812 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| 5UTR-3CDS | ENST00000486765 | ENST00000262318 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| 5UTR-3CDS | ENST00000486765 | ENST00000382745 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| 5UTR-3CDS | ENST00000486765 | ENST00000448525 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| 5UTR-intron | ENST00000486765 | ENST00000566812 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| In-frame | ENST00000361605 | ENST00000262318 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| In-frame | ENST00000361605 | ENST00000382745 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| In-frame | ENST00000361605 | ENST00000448525 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000361605 | C1orf174 | chr1 | 3809447 | - | ENST00000448525 | CLCN7 | chr16 | 1509188 | - | 3749 | 228 | 78 | 2051 | 657 |
| ENST00000361605 | C1orf174 | chr1 | 3809447 | - | ENST00000382745 | CLCN7 | chr16 | 1509188 | - | 3748 | 228 | 78 | 2051 | 657 |
| ENST00000361605 | C1orf174 | chr1 | 3809447 | - | ENST00000262318 | CLCN7 | chr16 | 1509188 | - | 3340 | 228 | 78 | 2411 | 777 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000361605 | ENST00000448525 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - | 0.005770122 | 0.9942299 |
| ENST00000361605 | ENST00000382745 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - | 0.005780984 | 0.99421906 |
| ENST00000361605 | ENST00000262318 | C1orf174 | chr1 | 3809447 | - | CLCN7 | chr16 | 1509188 | - | 0.014232678 | 0.98576736 |
Top |
Fusion Genomic Features for C1orf174-CLCN7 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for C1orf174-CLCN7 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:3809447/chr16:1509188) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | CLCN7 |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Slowly voltage-gated channel mediating the exchange of chloride ions against protons (PubMed:18449189, PubMed:21527911). Functions as antiporter and contributes to the acidification of the lysosome lumen and may be involved in maintaining lysosomal pH (PubMed:18449189, PubMed:21527911, PubMed:31155284). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (By similarity). The presence of conserved gating glutamate residues is typical for family members that function as antiporters (By similarity). {ECO:0000250|UniProtKB:P35523, ECO:0000269|PubMed:18449189, ECO:0000269|PubMed:21527911, ECO:0000269|PubMed:31155284}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 631_695 | 198 | 806.0 | Domain | CBS 1 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 741_799 | 198 | 806.0 | Domain | CBS 2 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 631_695 | 174 | 782.0 | Domain | CBS 1 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 741_799 | 174 | 782.0 | Domain | CBS 2 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 206_213 | 198 | 806.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 288_300 | 198 | 806.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 304_312 | 198 | 806.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 545_559 | 198 | 806.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 560_562 | 198 | 806.0 | Intramembrane | Note%3DLoop between two helices | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 563_574 | 198 | 806.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 575_578 | 198 | 806.0 | Intramembrane | Note%3DLoop between two helices | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 206_213 | 174 | 782.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 288_300 | 174 | 782.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 304_312 | 174 | 782.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 545_559 | 174 | 782.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 560_562 | 174 | 782.0 | Intramembrane | Note%3DLoop between two helices | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 563_574 | 174 | 782.0 | Intramembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 575_578 | 174 | 782.0 | Intramembrane | Note%3DLoop between two helices | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 203_207 | 198 | 806.0 | Motif | Selectivity filter part_1 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 245_249 | 198 | 806.0 | Motif | Selectivity filter part_2 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 512_516 | 198 | 806.0 | Motif | Selectivity filter part_3 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 203_207 | 174 | 782.0 | Motif | Selectivity filter part_1 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 245_249 | 174 | 782.0 | Motif | Selectivity filter part_2 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 512_516 | 174 | 782.0 | Motif | Selectivity filter part_3 | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 658_660 | 198 | 806.0 | Nucleotide binding | ATP | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 783_786 | 198 | 806.0 | Nucleotide binding | ATP | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 658_660 | 174 | 782.0 | Nucleotide binding | ATP | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 783_786 | 174 | 782.0 | Nucleotide binding | ATP | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 598_805 | 198 | 806.0 | Topological domain | Cytoplasmic | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 598_805 | 174 | 782.0 | Topological domain | Cytoplasmic | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 223_241 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 247_264 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 322_341 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 375_405 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 410_432 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 487_507 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 512_535 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 579_597 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 174_197 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 223_241 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 247_264 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 322_341 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 375_405 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 410_432 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 487_507 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 512_535 | 174 | 782.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 579_597 | 174 | 782.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | C1orf174 | chr1:3809447 | chr16:1509188 | ENST00000361605 | - | 2 | 4 | 232_240 | 43 | 244.0 | Compositional bias | Note=Poly-Asp |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 1_126 | 198 | 806.0 | Topological domain | Cytoplasmic | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 1_126 | 174 | 782.0 | Topological domain | Cytoplasmic | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 127_159 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000382745 | 5 | 25 | 174_197 | 198 | 806.0 | Transmembrane | Helical | |
| Tgene | CLCN7 | chr1:3809447 | chr16:1509188 | ENST00000448525 | 4 | 24 | 127_159 | 174 | 782.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for C1orf174-CLCN7 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >11321_11321_1_C1orf174-CLCN7_C1orf174_chr1_3809447_ENST00000361605_CLCN7_chr16_1509188_ENST00000262318_length(transcript)=3340nt_BP=228nt GTCGGACGCCGCCGCGGCGCGCTCTGCAGACTCCGGGTCGCCGCTCCGCCGGGACGCGTTGGCCGGGGCGCGCGGTGCTTGGCTGCGGTG CTCACACTCATGAGGAGCCGGAAGCTCACAGGTGCAGTGCGGTCTTCAGCGCGCTTGAAAGCACGAAGTTGTTCGGCAGCCAGGTTGGCC TCTGCCCAGGAAGTTGCTGGTTCCACGTCTGCCAAGACAGCATGTCTGCCGGTGGCTGCTGGCAGCGGAATCCCCCAGATCAAGTGCTTC CTCAACGGGGTGAAGATCCCCCACGTGGTGCGGCTCAAGACGTTGGTGATCAAAGTGTCCGGTGTGATCCTGTCCGTGGTCGGGGGCCTG GCCGTGGGAAAGGAAGGGCCGATGATCCACTCAGGTTCAGTGATTGCCGCCGGGATCTCTCAGGGAAGGTCAACGTCACTGAAACGAGAT TTCAAGATCTTCGAGTACTTCCGCAGAGACACAGAGAAGCGGGACTTCGTCTCCGCAGGGGCTGCGGCCGGAGTGTCAGCGGCGTTTGGA GCCCCCGTGGGTGGGGTCCTGTTCAGCTTGGAGGAGGGTGCGTCCTTCTGGAACCAGTTCCTGACCTGGAGGATCTTCTTTGCTTCCATG ATCTCCACGTTCACCCTGAATTTTGTTCTGAGCATTTACCACGGGAACATGTGGGACCTGTCCAGCCCAGGCCTCATCAACTTCGGAAGG TTTGACTCGGAGAAAATGGCCTACACGATCCACGAGATCCCGGTCTTCATCGCCATGGGCGTGGTGGGCGGTGTGCTTGGAGCAGTGTTC AATGCCTTGAACTACTGGCTGACCATGTTTCGAATCAGGTACATCCACCGGCCCTGCCTGCAGGTGATTGAGGCCGTGCTGGTGGCCGCC GTCACGGCCACAGTTGCCTTCGTGCTGATCTACTCGTCGCGGGATTGCCAGCCCCTGCAGGGGGGCTCCATGTCCTACCCGCTGCAGCTC TTTTGTGCAGATGGCGAGTACAACTCCATGGCTGCGGCCTTCTTCAACACCCCGGAGAAGAGCGTGGTGAGCCTCTTCCACGACCCGCCA GGCTCCTACAACCCCCTGACCCTCGGCCTGTTCACGCTGGTCTACTTCTTCCTGGCCTGCTGGACCTACGGGCTCACGGTGTCTGCCGGG GTCTTCATCCCGTCCCTGCTCATCGGGGCTGCCTGGGGCCGGCTCTTTGGGATCTCCCTGTCCTACCTCACGGGGGCGGCGATCTGGGCG GACCCCGGCAAATACGCCCTGATGGGAGCTGCTGCCCAGCTGGGCGGGATTGTGCGGATGACACTGAGCCTGACCGTCATCATGATGGAG GCCACCAGCAACGTGACCTACGGCTTCCCCATCATGCTGGTGCTCATGACCGCCAAGATCGTGGGCGACGTCTTCATTGAGGGCCTGTAC GACATGCACATTCAGCTGCAGAGTGTGCCCTTCCTGCACTGGGAGGCCCCGGTCACCTCACACTCACTCACTGCCAGGGAGGTGATGAGC ACACCAGTGACCTGCCTGAGGCGGCGTGAGAAGGTCGGCGTCATTGTGGACGTGCTGAGCGACACGGCGTCCAATCACAACGGCTTCCCC GTGGTGGAGCATGCCGATGACACCCAGCCTGCCCGGCTCCAGGGCCTGATCCTGCGCTCCCAGCTCATCGTTCTCCTAAAGCACAAGGTG TTTGTGGAGCGGTCCAACCTGGGCCTGGTACAGCGGCGCCTGAGGCTGAAGGACTTCCGAGACGCCTACCCGCGCTTCCCACCCATCCAG TCCATCCACGTGTCCCAGGACGAGCGGGAGTGCACCATGGACCTCTCCGAGTTCATGAACCCCTCCCCCTACACGGTGCCCCAGGCATGC GTCGCTCCCACGGGTGTTCAAGCTGTTCCGGGCCCTGGGCCTGCGGCACCTGGTGGTGGTGGACAACCGCAATCAGGTTGTCGGGTTGGT GACCAGGAAGGACCTCGCCAGGTACCGCCTGGGAAAGAGAGGCTTGGAGGAGCTCTCGCTGGCCCAGACGTGAGGCCCAGCCCTGCCCAT AATGGGCACTGGCGCTGGCACCCCGGCCCTTCTGCATTTCCTCCCGGAGTCACTGGTTTCTCGGCCCAAACCATGCTCCCCAGCAGTGGC AATGGCGAGCACCCTGCAGCTGGGCGGGCAGGCGGCAGGCGCGGAACTGACCCTCTCGCGGGACTGACCCTGTTGTGGGCAGTGGTCTCC CCCCTTGGCGCCTCCTTGCGCAGGCCCAGCCTCCACTCTCCTCGTCTAGGTTTCTTTACCTCCAGGGATCAGCTGTGTGTGTGTGACCTC CCTACCGGGCTATCGGCCTCTTGGGAGCCAGCGGCAGGGCCGGCACCTGCGTGCCTGTGCCCGTGTGCGTGAGACAGAGCCCTTGCCCCT GCTGCTGCCCCGAGGGCTGCCCTGCCCTGGAAGGGCCCCTCTGCCTCCACACCAGTGGAGTCTTCGAGACTTGGGAGCTGCTTGGCCTCA TTTTCAGCCATGAGCAGACGGCCTGTGGTCCCTGGGCCTGAGGCACGGACTCGTAGCACCAGGGTTTGGAGGCTGCGACCGCCCCGGAGA GCAGCTTCACACTGGCGCCACAGAGGAGCCCCACGTGCACTCCCCGGCCTGCATCCGGCTTGGGTACACAGGCCCAGAGGACTGGGGTGA CTCACGGGCCCTGTGCTGTGATGTTGAGAGCTGAGAAAAACCTCCAAGGCCCTGAGCCCCATGCCCAGCCCTGCCTTGGTCCCCCAACCC CCAGAGCTTGGAGTCTGGGCCCCACACCCAGCCCTGCCTTGGTCCCTGAGCCTCAGAGCGTGGAATTGCTGCCCTGTGGACACTGGCTGG GAAGGCAGGTCTTCCCCTAGCACATGGGGACCCCGGCCTCGAGGGTGACCTCCCTACCCCGCCCCTGCCAGCCACCAAGCGCAGGTGCAG CGGGGGCCAGACTCCTGCCGGCCTCAGAGGACACCTGGCCCAGCACAGGCAGCTAGAAGGGCCGGTGGGCACCGGGGCCGGGAAGCCCCC ACCTCACCACCTGAGGGCCCCTGGGAGGCTCCTCTGGCCTGGCTGGGCTGGGTCTGGGGCCGCCACAGGCCCCTCACGGGGCGGCAGAGG CAACTTCAGTGTCCCTGTTAGAGCAACACGGGTCCCTCCGTGGGGGGCTGGGTGCGGCCCCCTGCCGTGTATTTCCTCCCCAGGGAGTGG GGCCTCCCCGGGAGCTGACGCCACCACCCTGCTTAGCCCTCACAGGGCCCCAAGGTGTCCGAGTGTGTTGGGTCTGAACGCGAAATAAAG >11321_11321_1_C1orf174-CLCN7_C1orf174_chr1_3809447_ENST00000361605_CLCN7_chr16_1509188_ENST00000262318_length(amino acids)=777AA_BP=50 MAAVLTLMRSRKLTGAVRSSARLKARSCSAARLASAQEVAGSTSAKTACLPVAAGSGIPQIKCFLNGVKIPHVVRLKTLVIKVSGVILSV VGGLAVGKEGPMIHSGSVIAAGISQGRSTSLKRDFKIFEYFRRDTEKRDFVSAGAAAGVSAAFGAPVGGVLFSLEEGASFWNQFLTWRIF FASMISTFTLNFVLSIYHGNMWDLSSPGLINFGRFDSEKMAYTIHEIPVFIAMGVVGGVLGAVFNALNYWLTMFRIRYIHRPCLQVIEAV LVAAVTATVAFVLIYSSRDCQPLQGGSMSYPLQLFCADGEYNSMAAAFFNTPEKSVVSLFHDPPGSYNPLTLGLFTLVYFFLACWTYGLT VSAGVFIPSLLIGAAWGRLFGISLSYLTGAAIWADPGKYALMGAAAQLGGIVRMTLSLTVIMMEATSNVTYGFPIMLVLMTAKIVGDVFI EGLYDMHIQLQSVPFLHWEAPVTSHSLTAREVMSTPVTCLRRREKVGVIVDVLSDTASNHNGFPVVEHADDTQPARLQGLILRSQLIVLL KHKVFVERSNLGLVQRRLRLKDFRDAYPRFPPIQSIHVSQDERECTMDLSEFMNPSPYTVPQACVAPTGVQAVPGPGPAAPGGGGQPQSG CRVGDQEGPRQVPPGKERLGGALAGPDVRPSPAHNGHWRWHPGPSAFPPGVTGFSAQTMLPSSGNGEHPAAGRAGGRRGTDPLAGLTLLW -------------------------------------------------------------- >11321_11321_2_C1orf174-CLCN7_C1orf174_chr1_3809447_ENST00000361605_CLCN7_chr16_1509188_ENST00000382745_length(transcript)=3748nt_BP=228nt GTCGGACGCCGCCGCGGCGCGCTCTGCAGACTCCGGGTCGCCGCTCCGCCGGGACGCGTTGGCCGGGGCGCGCGGTGCTTGGCTGCGGTG CTCACACTCATGAGGAGCCGGAAGCTCACAGGTGCAGTGCGGTCTTCAGCGCGCTTGAAAGCACGAAGTTGTTCGGCAGCCAGGTTGGCC TCTGCCCAGGAAGTTGCTGGTTCCACGTCTGCCAAGACAGCATGTCTGCCGGTGGCTGCTGGCAGCGGAATCCCCCAGATCAAGTGCTTC CTCAACGGGGTGAAGATCCCCCACGTGGTGCGGCTCAAGACGTTGGTGATCAAAGTGTCCGGTGTGATCCTGTCCGTGGTCGGGGGCCTG GCCGTGGGAAAGGAAGGGCCGATGATCCACTCAGGTTCAGTGATTGCCGCCGGGATCTCTCAGGGAAGGTCAACGTCACTGAAACGAGAT TTCAAGATCTTCGAGTACTTCCGCAGAGACACAGAGAAGCGGGACTTCGTCTCCGCAGGGGCTGCGGCCGGAGTGTCAGCGGCGTTTGGA GCCCCCGTGGGTGGGGTCCTGTTCAGCTTGGAGGAGGGTGCGTCCTTCTGGAACCAGTTCCTGACCTGGAGGATCTTCTTTGCTTCCATG ATCTCCACGTTCACCCTGAATTTTGTTCTGAGCATTTACCACGGGAACATGTGGGACCTGTCCAGCCCAGGCCTCATCAACTTCGGAAGG TTTGACTCGGAGAAAATGGCCTACACGATCCACGAGATCCCGGTCTTCATCGCCATGGGCGTGGTGGGCGGTGTGCTTGGAGCAGTGTTC AATGCCTTGAACTACTGGCTGACCATGTTTCGAATCAGGTACATCCACCGGCCCTGCCTGCAGGTGATTGAGGCCGTGCTGGTGGCCGCC GTCACGGCCACAGTTGCCTTCGTGCTGATCTACTCGTCGCGGGATTGCCAGCCCCTGCAGGGGGGCTCCATGTCCTACCCGCTGCAGCTC TTTTGTGCAGATGGCGAGTACAACTCCATGGCTGCGGCCTTCTTCAACACCCCGGAGAAGAGCGTGGTGAGCCTCTTCCACGACCCGCCA GGCTCCTACAACCCCCTGACCCTCGGCCTGTTCACGCTGGTCTACTTCTTCCTGGCCTGCTGGACCTACGGGCTCACGGTGTCTGCCGGG GTCTTCATCCCGTCCCTGCTCATCGGGGCTGCCTGGGGCCGGCTCTTTGGGATCTCCCTGTCCTACCTCACGGGGGCGGCGATCTGGGCG GACCCCGGCAAATACGCCCTGATGGGAGCTGCTGCCCAGCTGGGCGGGATTGTGCGGATGACACTGAGCCTGACCGTCATCATGATGGAG GCCACCAGCAACGTGACCTACGGCTTCCCCATCATGCTGGTGCTCATGACCGCCAAGATCGTGGGCGACGTCTTCATTGAGGGCCTGTAC GACATGCACATTCAGCTGCAGAGTGTGCCCTTCCTGCACTGGGAGGCCCCGGTCACCTCACACTCACTCACTGCCAGGGAGGTGATGAGC ACACCAGTGACCTGCCTGAGGCGGCGTGAGAAGGTCGGCGTCATTGTGGACGTGCTGAGCGACACGGCGTCCAATCACAACGGCTTCCCC GTGGTGGAGCATGCCGATGACACCCAGCCTGCCCGGCTCCAGGGCCTGATCCTGCGCTCCCAGCTCATCGTTCTCCTAAAGCACAAGGTG TTTGTGGAGCGGTCCAACCTGGGCCTGGTACAGCGGCGCCTGAGGCTGAAGGACTTCCGAGACGCCTACCCGCGCTTCCCACCCATCCAG TCCATCCACGTGTCCCAGGACGAGCGGGAGTGCACCATGGACCTCTCCGAGTTCATGAACCCCTCCCCCTACACGGTGCCCCAGGAGGCG TCGCTCCCACGGGTGTTCAAGCTGTTCCGGGCCCTGGGCCTGCGGCACCTGGTGGTGGTGGACAACCGCAATCAGGTTGTCGGGTTGGTG ACCAGGAAGGACCTCGCCAGGTACCGCCTGGGAAAGAGAGGCTTGGAGGAGCTCTCGCTGGCCCAGACGTGAGGCCCAGCCCTGCCCATA ATGGGCACTGGCGCTGGCACCCCGGCCCTTCTGCATTTCCTCCCGGAGTCACTGGTTTCTCGGCCCAAACCATGCTCCCCAGCAGTGGCA ATGGCGAGCACCCTGCAGCTGGGCGGGCAGGCGGCAGGCGCGGAACTGACCCTCTCGCGGGACTGACCCTGTTGTGGGCAGTGGTCTCCC CCCTTGGCGCCTCCTTGCGCAGGCCCAGCCTCCACTCTCCTCGTCTAGGTTTCTTTACCTCCAGGGATCAGCTGTGTGTGTGTGACCTCC CTACCGGGCTATCGGCCTCTTGGGAGCCAGCGGCAGGGCCGGCACCTGCGTGCCTGTGCCCGTGTGCGTGAGACAGAGCCCTTGCCCCTG CTGCTGCCCCGAGGGCTGCCCTGCCCTGGAAGGGCCCCTCTGCCTCCACACCAGTGGAGTCTTCGAGACTTGGGAGCTGCTTGGCCTCAT TTTCAGCCATGAGCAGACGGCCTGTGGTCCCTGGGCCTGAGGCACGGACTCGTAGCACCAGGGTTTGGAGGCTGCGACCGCCCCGGAGAG CAGCTTCACACTGGCGCCACAGAGGAGCCCCACGTGCACTCCCCGGCCTGCATCCGGCTTGGGTACACAGGCCCAGAGGACTGGGGTGAC TCACGGGCCCTGTGCTGTGATGTTGAGAGCTGAGAAAAACCTCCAAGGCCCTGAGCCCCATGCCCAGCCCTGCCTTGGTCCCCCAACCCC CAGAGCTTGGAGTCTGGGCCCCACACCCAGCCCTGCCTTGGTCCCTGAGCCTCAGAGCGTGGAATTGCTGCCCTGTGGACACTGGCTGGG AAGGCAGGTCTTCCCCTAGCACATGGGGACCCCGGCCTCGAGGGTGACCTCCCTACCCCGCCCCTGCCAGCCACCAAGCGCAGGTGCAGC GGGGGCCAGACTCCTGCCGGCCTCAGAGGACACCTGGCCCAGCACAGGCAGCTAGAAGGGCCGGTGGGCACCGGGGCCGGGAAGCCCCCA CCTCACCACCTGAGGGCCCCTGGGAGGCTCCTCTGGCCTGGCTGGGCTGGGTCTGGGGCCGCCACAGGCCCCTCACGGGGCGGCAGAGGC AACTTCAGTGTCCCTGTTAGAGCAACACGGGTCCCTCCGTGGGGGGCTGGGTGCGGCCCCCTGCCGTGTATTTCCTCCCCAGGGAGTGGG GCCTCCCCGGGAGCTGACGCCACCACCCTGCTTAGCCCTCACAGGGCCCCAAGGTGTCCGAGTGTGTTGGGTCTGAACGCGAAATAAAGA AATCCTCTCAGCCCGCCTTTGCCAGCGTCGTCCCTCCCACCCCACCCAGACCACGTCCAACAGCCTGGGACTTTCGGGACCCTGGGGTCG GGGCACCGTGTGGAGTGAGAAAGGCGTGAAAGACAGCGGCTGCGGCCACCCAGGGCACCAGCCACATCCTCTTCCTCGTCCCCGCCCCTC AGCCTCCCTCCTCTGGCTCCTGGCTGGTGGGTCTGGGGGCAAGGCAGAGGCGCTCCAGGTGGAGGGGGGCGGGCCGGGGTGCCCACGCTG GGGTGACGCAAGAAGAAAACTCCCGGGCCTCAGAGTCGGCGCCGGAAACCTAGGTCTGGGTTTCCCTCGTGGTGGTTGTGTACTGAGGAC >11321_11321_2_C1orf174-CLCN7_C1orf174_chr1_3809447_ENST00000361605_CLCN7_chr16_1509188_ENST00000382745_length(amino acids)=657AA_BP=50 MAAVLTLMRSRKLTGAVRSSARLKARSCSAARLASAQEVAGSTSAKTACLPVAAGSGIPQIKCFLNGVKIPHVVRLKTLVIKVSGVILSV VGGLAVGKEGPMIHSGSVIAAGISQGRSTSLKRDFKIFEYFRRDTEKRDFVSAGAAAGVSAAFGAPVGGVLFSLEEGASFWNQFLTWRIF FASMISTFTLNFVLSIYHGNMWDLSSPGLINFGRFDSEKMAYTIHEIPVFIAMGVVGGVLGAVFNALNYWLTMFRIRYIHRPCLQVIEAV LVAAVTATVAFVLIYSSRDCQPLQGGSMSYPLQLFCADGEYNSMAAAFFNTPEKSVVSLFHDPPGSYNPLTLGLFTLVYFFLACWTYGLT VSAGVFIPSLLIGAAWGRLFGISLSYLTGAAIWADPGKYALMGAAAQLGGIVRMTLSLTVIMMEATSNVTYGFPIMLVLMTAKIVGDVFI EGLYDMHIQLQSVPFLHWEAPVTSHSLTAREVMSTPVTCLRRREKVGVIVDVLSDTASNHNGFPVVEHADDTQPARLQGLILRSQLIVLL KHKVFVERSNLGLVQRRLRLKDFRDAYPRFPPIQSIHVSQDERECTMDLSEFMNPSPYTVPQEASLPRVFKLFRALGLRHLVVVDNRNQV -------------------------------------------------------------- >11321_11321_3_C1orf174-CLCN7_C1orf174_chr1_3809447_ENST00000361605_CLCN7_chr16_1509188_ENST00000448525_length(transcript)=3749nt_BP=228nt GTCGGACGCCGCCGCGGCGCGCTCTGCAGACTCCGGGTCGCCGCTCCGCCGGGACGCGTTGGCCGGGGCGCGCGGTGCTTGGCTGCGGTG CTCACACTCATGAGGAGCCGGAAGCTCACAGGTGCAGTGCGGTCTTCAGCGCGCTTGAAAGCACGAAGTTGTTCGGCAGCCAGGTTGGCC TCTGCCCAGGAAGTTGCTGGTTCCACGTCTGCCAAGACAGCATGTCTGCCGGTGGCTGCTGGCAGCGGAATCCCCCAGATCAAGTGCTTC CTCAACGGGGTGAAGATCCCCCACGTGGTGCGGCTCAAGACGTTGGTGATCAAAGTGTCCGGTGTGATCCTGTCCGTGGTCGGGGGCCTG GCCGTGGGAAAGGAAGGGCCGATGATCCACTCAGGTTCAGTGATTGCCGCCGGGATCTCTCAGGGAAGGTCAACGTCACTGAAACGAGAT TTCAAGATCTTCGAGTACTTCCGCAGAGACACAGAGAAGCGGGACTTCGTCTCCGCAGGGGCTGCGGCCGGAGTGTCAGCGGCGTTTGGA GCCCCCGTGGGTGGGGTCCTGTTCAGCTTGGAGGAGGGTGCGTCCTTCTGGAACCAGTTCCTGACCTGGAGGATCTTCTTTGCTTCCATG ATCTCCACGTTCACCCTGAATTTTGTTCTGAGCATTTACCACGGGAACATGTGGGACCTGTCCAGCCCAGGCCTCATCAACTTCGGAAGG TTTGACTCGGAGAAAATGGCCTACACGATCCACGAGATCCCGGTCTTCATCGCCATGGGCGTGGTGGGCGGTGTGCTTGGAGCAGTGTTC AATGCCTTGAACTACTGGCTGACCATGTTTCGAATCAGGTACATCCACCGGCCCTGCCTGCAGGTGATTGAGGCCGTGCTGGTGGCCGCC GTCACGGCCACAGTTGCCTTCGTGCTGATCTACTCGTCGCGGGATTGCCAGCCCCTGCAGGGGGGCTCCATGTCCTACCCGCTGCAGCTC TTTTGTGCAGATGGCGAGTACAACTCCATGGCTGCGGCCTTCTTCAACACCCCGGAGAAGAGCGTGGTGAGCCTCTTCCACGACCCGCCA GGCTCCTACAACCCCCTGACCCTCGGCCTGTTCACGCTGGTCTACTTCTTCCTGGCCTGCTGGACCTACGGGCTCACGGTGTCTGCCGGG GTCTTCATCCCGTCCCTGCTCATCGGGGCTGCCTGGGGCCGGCTCTTTGGGATCTCCCTGTCCTACCTCACGGGGGCGGCGATCTGGGCG GACCCCGGCAAATACGCCCTGATGGGAGCTGCTGCCCAGCTGGGCGGGATTGTGCGGATGACACTGAGCCTGACCGTCATCATGATGGAG GCCACCAGCAACGTGACCTACGGCTTCCCCATCATGCTGGTGCTCATGACCGCCAAGATCGTGGGCGACGTCTTCATTGAGGGCCTGTAC GACATGCACATTCAGCTGCAGAGTGTGCCCTTCCTGCACTGGGAGGCCCCGGTCACCTCACACTCACTCACTGCCAGGGAGGTGATGAGC ACACCAGTGACCTGCCTGAGGCGGCGTGAGAAGGTCGGCGTCATTGTGGACGTGCTGAGCGACACGGCGTCCAATCACAACGGCTTCCCC GTGGTGGAGCATGCCGATGACACCCAGCCTGCCCGGCTCCAGGGCCTGATCCTGCGCTCCCAGCTCATCGTTCTCCTAAAGCACAAGGTG TTTGTGGAGCGGTCCAACCTGGGCCTGGTACAGCGGCGCCTGAGGCTGAAGGACTTCCGAGACGCCTACCCGCGCTTCCCACCCATCCAG TCCATCCACGTGTCCCAGGACGAGCGGGAGTGCACCATGGACCTCTCCGAGTTCATGAACCCCTCCCCCTACACGGTGCCCCAGGAGGCG TCGCTCCCACGGGTGTTCAAGCTGTTCCGGGCCCTGGGCCTGCGGCACCTGGTGGTGGTGGACAACCGCAATCAGGTTGTCGGGTTGGTG ACCAGGAAGGACCTCGCCAGGTACCGCCTGGGAAAGAGAGGCTTGGAGGAGCTCTCGCTGGCCCAGACGTGAGGCCCAGCCCTGCCCATA ATGGGCACTGGCGCTGGCACCCCGGCCCTTCTGCATTTCCTCCCGGAGTCACTGGTTTCTCGGCCCAAACCATGCTCCCCAGCAGTGGCA ATGGCGAGCACCCTGCAGCTGGGCGGGCAGGCGGCAGGCGCGGAACTGACCCTCTCGCGGGACTGACCCTGTTGTGGGCAGTGGTCTCCC CCCTTGGCGCCTCCTTGCGCAGGCCCAGCCTCCACTCTCCTCGTCTAGGTTTCTTTACCTCCAGGGATCAGCTGTGTGTGTGTGACCTCC CTACCGGGCTATCGGCCTCTTGGGAGCCAGCGGCAGGGCCGGCACCTGCGTGCCTGTGCCCGTGTGCGTGAGACAGAGCCCTTGCCCCTG CTGCTGCCCCGAGGGCTGCCCTGCCCTGGAAGGGCCCCTCTGCCTCCACACCAGTGGAGTCTTCGAGACTTGGGAGCTGCTTGGCCTCAT TTTCAGCCATGAGCAGACGGCCTGTGGTCCCTGGGCCTGAGGCACGGACTCGTAGCACCAGGGTTTGGAGGCTGCGACCGCCCCGGAGAG CAGCTTCACACTGGCGCCACAGAGGAGCCCCACGTGCACTCCCCGGCCTGCATCCGGCTTGGGTACACAGGCCCAGAGGACTGGGGTGAC TCACGGGCCCTGTGCTGTGATGTTGAGAGCTGAGAAAAACCTCCAAGGCCCTGAGCCCCATGCCCAGCCCTGCCTTGGTCCCCCAACCCC CAGAGCTTGGAGTCTGGGCCCCACACCCAGCCCTGCCTTGGTCCCTGAGCCTCAGAGCGTGGAATTGCTGCCCTGTGGACACTGGCTGGG AAGGCAGGTCTTCCCCTAGCACATGGGGACCCCGGCCTCGAGGGTGACCTCCCTACCCCGCCCCTGCCAGCCACCAAGCGCAGGTGCAGC GGGGGCCAGACTCCTGCCGGCCTCAGAGGACACCTGGCCCAGCACAGGCAGCTAGAAGGGCCGGTGGGCACCGGGGCCGGGAAGCCCCCA CCTCACCACCTGAGGGCCCCTGGGAGGCTCCTCTGGCCTGGCTGGGCTGGGTCTGGGGCCGCCACAGGCCCCTCACGGGGCGGCAGAGGC AACTTCAGTGTCCCTGTTAGAGCAACACGGGTCCCTCCGTGGGGGGCTGGGTGCGGCCCCCTGCCGTGTATTTCCTCCCCAGGGAGTGGG GCCTCCCCGGGAGCTGACGCCACCACCCTGCTTAGCCCTCACAGGGCCCCAAGGTGTCCGAGTGTGTTGGGTCTGAACGCGAAATAAAGA AATCCTCTCAGCCCGCCTTTGCCAGCGTCGTCCCTCCCACCCCACCCAGACCACGTCCAACAGCCTGGGACTTTCGGGACCCTGGGGTCG GGGCACCGTGTGGAGTGAGAAAGGCGTGAAAGACAGCGGCTGCGGCCACCCAGGGCACCAGCCACATCCTCTTCCTCGTCCCCGCCCCTC AGCCTCCCTCCTCTGGCTCCTGGCTGGTGGGTCTGGGGGCAAGGCAGAGGCGCTCCAGGTGGAGGGGGGCGGGCCGGGGTGCCCACGCTG GGGTGACGCAAGAAGAAAACTCCCGGGCCTCAGAGTCGGCGCCGGAAACCTAGGTCTGGGTTTCCCTCGTGGTGGTTGTGTACTGAGGAC >11321_11321_3_C1orf174-CLCN7_C1orf174_chr1_3809447_ENST00000361605_CLCN7_chr16_1509188_ENST00000448525_length(amino acids)=657AA_BP=50 MAAVLTLMRSRKLTGAVRSSARLKARSCSAARLASAQEVAGSTSAKTACLPVAAGSGIPQIKCFLNGVKIPHVVRLKTLVIKVSGVILSV VGGLAVGKEGPMIHSGSVIAAGISQGRSTSLKRDFKIFEYFRRDTEKRDFVSAGAAAGVSAAFGAPVGGVLFSLEEGASFWNQFLTWRIF FASMISTFTLNFVLSIYHGNMWDLSSPGLINFGRFDSEKMAYTIHEIPVFIAMGVVGGVLGAVFNALNYWLTMFRIRYIHRPCLQVIEAV LVAAVTATVAFVLIYSSRDCQPLQGGSMSYPLQLFCADGEYNSMAAAFFNTPEKSVVSLFHDPPGSYNPLTLGLFTLVYFFLACWTYGLT VSAGVFIPSLLIGAAWGRLFGISLSYLTGAAIWADPGKYALMGAAAQLGGIVRMTLSLTVIMMEATSNVTYGFPIMLVLMTAKIVGDVFI EGLYDMHIQLQSVPFLHWEAPVTSHSLTAREVMSTPVTCLRRREKVGVIVDVLSDTASNHNGFPVVEHADDTQPARLQGLILRSQLIVLL KHKVFVERSNLGLVQRRLRLKDFRDAYPRFPPIQSIHVSQDERECTMDLSEFMNPSPYTVPQEASLPRVFKLFRALGLRHLVVVDNRNQV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for C1orf174-CLCN7 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for C1orf174-CLCN7 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for C1orf174-CLCN7 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies